ADAM8 is associated with asthma exacerbation by promoting lung macrophages apoptosis resistance through PI3K/AKT signaling pathway
Abstract
IntroductionDespite advances in asthma management, asthma exacerbations (AE) remain a leading cause of morbidity, and the immunopathological mechanisms driving AE progression need further clarification. Here, we explored the role of macrophage apoptosis resistance in AE using clinical samples and murine models.MethodsMacrophages were isolated from bronchoalveolar lavage fluid (BALF) of AE patients and lung macrophages from AE mice to detect Bcl-2 expression and apoptosis. We performed adoptive transfer of ex vivo apoptotic bone marrow-derived macrophages (BMDMs) and ADAM8-silenced BMDMs. Integrative transcriptomic analysis of GSE144576 combined with in vivo validation was used to screen regulators of lung macrophage apoptosis resistance. In vitro and in vivo experiments with the peptidomimetic inhibitor BK1361 were conducted to dissect ADAM8 downstream signaling.ResultsMacrophages from AE patients and AE mice showed elevated Bcl-2 and strong apoptosis resistance. Adoptive transfer of apoptotic BMDMs partially reversed macrophage apoptosis resistance and mitigated airway inflammation. Transcriptomics plus animal validation identified ADAM8 as a regulator of macrophage apoptosis resistance. Consistently, transfer of ADAM8-silenced BMDMs relieved airway inflammation and reduced apoptosis resistance. Mechanistically, ADAM8 may activate PI3K/AKT signaling to upregulate Bcl-2 and promote apoptosis resistance. BK1361 suppressed ADAM8/PI3K/AKT signaling, enhanced macrophage apoptosis, and reduced inflammatory infiltration, mucus hypersecretion, and airway hyperresponsiveness (AHR) in AE mice.DiscussionIn summary, macrophage apoptosis resistance drives inflammatory amplification in AE. The ADAM8/PI3K/AKT axis mediates this phenotype, indicating ADAM8 as a promising therapeutic target for AE.
Related
- Reprogramming tumor-associated macrophages in breast cancer: from myeloid plasticity and tumor-promoting programs to CAR-macrophage therapy.
- CFI-400945 enhances radiosensitivity in colorectal cancer models by promoting mitotic dysregulation and DNA damage-associated apoptosis.
- Selenium-Enriched Rapeseed Extract Synergizes with Chemotherapy Drug Cisplatin in Inhibiting Proliferation and Promoting Apoptosis of Colorectal Cancer Cells
- COX2 contributes to the spatial reorganization of B7H4⁺ and CD44v6⁺ niches promoting therapy resistance in ER- breast cancer
- Clinical variables and quantitative CT radiomics for mortality risk stratification after acute exacerbation of idiopathic inflammatory myopathy-associated interstitial lung disease
BibTeX
@article{chen2026adam8,
title = {{ADAM8 is associated with asthma exacerbation by promoting lung macrophages apoptosis resistance through PI3K/AKT signaling pathway}},
author = {Long Chen and Xinyu Wu and Huijun Liu and Qizhi Luo and Lin Yuan and Qiuyan Qin and Qianyu Zhao and Jia Wang and Chi Liu},
journal = {Frontiers in Immunology},
year = {2026},
month = nov,
doi = {10.3389/fimmu.2026.1869233},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1869233},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - ADAM8 is associated with asthma exacerbation by promoting lung macrophages apoptosis resistance through PI3K/AKT signaling pathway
AU - Long Chen
AU - Xinyu Wu
AU - Huijun Liu
AU - Qizhi Luo
AU - Lin Yuan
AU - Qiuyan Qin
AU - Qianyu Zhao
AU - Jia Wang
AU - Chi Liu
PY - 2026
DA - 2026/11/02
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1869233
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1869233
AB - IntroductionDespite advances in asthma management, asthma exacerbations (AE) remain a leading cause of morbidity, and the immunopathological mechanisms driving AE progression need further clarification. Here, we explored the role of macrophage apoptosis resistance in AE using clinical samples and murine models.MethodsMacrophages were isolated from bronchoalveolar lavage fluid (BALF) of AE patients and lung macrophages from AE mice to detect Bcl-2 expression and apoptosis. We performed adoptive transfer of ex vivo apoptotic bone marrow-derived macrophages (BMDMs) and ADAM8-silenced BMDMs. Integrative transcriptomic analysis of GSE144576 combined with in vivo validation was used to screen regulators of lung macrophage apoptosis resistance. In vitro and in vivo experiments with the peptidomimetic inhibitor BK1361 were conducted to dissect ADAM8 downstream signaling.ResultsMacrophages from AE patients and AE mice showed elevated Bcl-2 and strong apoptosis resistance. Adoptive transfer of apoptotic BMDMs partially reversed macrophage apoptosis resistance and mitigated airway inflammation. Transcriptomics plus animal validation identified ADAM8 as a regulator of macrophage apoptosis resistance. Consistently, transfer of ADAM8-silenced BMDMs relieved airway inflammation and reduced apoptosis resistance. Mechanistically, ADAM8 may activate PI3K/AKT signaling to upregulate Bcl-2 and promote apoptosis resistance. BK1361 suppressed ADAM8/PI3K/AKT signaling, enhanced macrophage apoptosis, and reduced inflammatory infiltration, mucus hypersecretion, and airway hyperresponsiveness (AHR) in AE mice.DiscussionIn summary, macrophage apoptosis resistance drives inflammatory amplification in AE. The ADAM8/PI3K/AKT axis mediates this phenotype, indicating ADAM8 as a promising therapeutic target for AE.
SN - 1664-3224
ER -